• Remdesivir receives conditional approval in the EU (which is valid for 12 months; after that it can be extended or become unlimited, pending assessment of confirmatory data. Source
• A pre-print paper- which has not been peer-reviewed – links the major genetic risk factor for severe COVID-19 with Neandertals; it is most common in Bangladesh (63%), followed by South Asia (30%), Europe (8%) and the US (4%) – and almost absent in Africa. Source
